No Data
No Data
No Data
No Data
No Data
Kangwei Century (688426.SH) issued 2023 annual results with a net loss of 84.4095 million yuan
Kangwei Century (688426.SH) released its 2023 annual report. The company achieved operating income of 1 during the reporting period...
Zhitong FinanceApr 25 08:04 ET
Kangwei Century (688426.SH): A total cost of 10.166 million yuan to buy back 0.4333% of the shares
Gelonghui, April 1, 丨 Kang Wei Century (688426.SH) announced that by the close of trading on March 29, 2024, the company had repurchased 487,427 shares of the company through centralized bidding transactions, accounting for 0.4333% of the company's total share capital of 112,493,716 shares. The highest price of the repurchase transaction was 22.48 yuan/share, the lowest price was 20.01 yuan/share, and the total amount of capital paid was RMB 10,166,439.03 (excluding transaction fees such as stamp duty and transaction fees).
Gelonghui FinanceApr 1 04:37 ET
Kangwei Century (688426.SH): First repurchase of 59,000 shares
Gelonghui, March 4, 丨 Kang Wei Century (688426.SH) announced that on March 4, 2024, Jiangsu Kangwei Century Biotechnology Co., Ltd. repurchased 59,262 shares of the company's shares for the first time through centralized bidding transactions, accounting for 0.0528% of the company's total share capital of 112,227,568 shares. The highest price for the repurchase transaction was 21.64 yuan/share, and the lowest price was 20.98 yuan/share. The total amount of capital paid was RMB 1,274,479.33.
Gelonghui FinanceMar 4 05:22 ET
Kangwei Century (688426.SH): net loss of 81.013,600 yuan in 2023
Gelonghui, Feb. 27丨Kang Wei Century (688426.SH) announced the 2023 Annual Results Report. During the reporting period, the company achieved operating income of 177.455,800 yuan, a year-on-year decrease of 65.98%; realized total profit of -86.773,900 yuan, a year-on-year decrease of 144.41%; realized net profit attributable to owners of the parent company - 81.013,600 yuan, a year-on-year decrease of 150.87%; realized net profit attributable to owners of the parent company - 116.5982 million yuan, a year-on-year decrease of 116.5982 million yuan, a year-on-year decrease of 116.5982 million yuan. 178.31%
Gelonghui FinanceFeb 27 04:55 ET
Kangwei Century (688426.SH): Plans to buy back 30 million yuan to 60 million yuan of company shares
Gelonghui, Feb. 6: Kang Wei Century (688426.SH) announced that the proposed repurchase scale will not be less than RMB 30 million, no more than RMB 60 million of the company's shares, and the repurchase price will not exceed RMB 25.88 per share.
Gelonghui FinanceFeb 6 05:20 ET
Jiangsu CoWin Biotech Co., Ltd.'s (SHSE:688426) 37% Share Price Plunge Could Signal Some Risk
The Jiangsu CoWin Biotech Co., Ltd. (SHSE:688426) share price has fared very poorly over the last month, falling by a substantial 37%. For any long-term shareholders, the last month ends a year to
Simply Wall StFeb 4 19:03 ET
No Data
No Data